WESTMINSTER RADAR
Search
My MPs
Menu

Question follow-through · 37487

Myasthenia Gravis: Medical Treatments

To ask the Secretary of State for Health and Social Care, what steps he has taken to increase patient access to new and innovative treatments for Myasthenia Gravis.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
11 Mar 2025
Target answer date
13 Mar 2025
Answer
17 Mar 2025 · 6 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 11 Mar 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, what steps he has taken to increase patient access to new and innovative treatments for Myasthenia Gravis.

  2. 13 Mar 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 17 Mar 2025

    Answer published

    The Government is committed to improving the lives of those living with rare diseases, such as myasthenia gravis. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community: these include improving ac...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Care Homes: Drugs

30 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made on the adequacy of access to (a) medicines and (b) controlled drugs in care homes in North Somerset.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Care Homes: Drugs

30 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of regulation of access to controlled drugs in care homes in North Somerset.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services

12 May 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to include policies on self-care within the forthcoming 10-year Health Plan.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS England: Drugs

22 May 2025 · To ask the Secretary of State for Health and Social Care, how many commercial agreements NHS England has made with manufacturers of medicines which have r resulted in indication-specific pricing between January 2020 and March 2025; and what therapeutic ar

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Life Sciences

22 May 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NHS England’s criterion for eligibility for indication-specific pricing to demonstrate revenue loss on the UK’s international competitiveness

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services

3 Jun 2025 · To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 16 May 2025 to Question 51728, what steps he is taking to ensure that patients (a) improve and (b) protect their own health.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pharmacy: Fees and Charges

3 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to prevent spoke pharmacies from charging patients for additional services which are delivered by an outsourced hub partner.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Nurses: Schools

10 Jun 2025 · To ask the Secretary of State for Health and Social Care, how many and what proportion of school nurses have received specialist training in (a) allergy and (b) anaphylaxis management.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Bladder Cancer: Health Services

23 Jun 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of care for bladder cancer in each region; and if he will hold discussions with NICE guidelines on the time taken to update its guidelines on

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Respiratory Syncytial Virus: Vaccination

24 Jun 2025 · To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of (a) hospitalisations and (b) deaths that have been prevented by RSV vaccines administered through the early adopter community pharmacy sites.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pharmacy: Training

24 Jun 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure a sufficient number of Designated Prescribing Practitioners to mentor all new non-medical prescribers.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Drugs

18 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify which medicines have a large number of indications